Association between selective serotonin reuptake inhibitor use and developing irritable bowel syndrome through retrospective analysis.

Kwak, Nayoung; Lee, Hankil; Kim, Beom Kyung; Yu, Yun Mi; Kang, Hye-Young

Kwak, Nayoung; Lee, Hankil; Kim, Beom Kyung; Yu, Yun Mi; Kang, Hye-Young.

Affiliation

Kwak N; Graduate Program of Industrial Pharmaceutical Science, Yonsei University, Incheon, Korea.
Lee H; College of Pharmacy, Ajou University, Suwon, Korea.
Kim BK; Department of Biohealth Regulatory Science, Graduate School of Ajou University, Suwon, Korea.
Yu YM; Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea.
Kang HY; Institute of Gastroenterology, Yonsei University College of Medicine, Seoul, Korea.

J Gastroenterol Hepatol ; 39(2): 280-288, 2024 Feb.

Article in En | MEDLINE | ID: mdl-37961007

Subject(s)

Irritable Bowel Syndrome; Selective Serotonin Reuptake Inhibitors; Humans; Selective Serotonin Reuptake Inhibitors/adverse effects; Retrospective Studies; Irritable Bowel Syndrome/chemically induced; Irritable Bowel Syndrome/epidemiology; Irritable Bowel Syndrome/drug therapy; Incidence; Proportional Hazards Models

Key words

brain-gut-microbiome axis; irritable bowel syndrome; selective serotonin reuptake inhibitors

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Selective Serotonin Reuptake Inhibitors / Irritable Bowel Syndrome Limits: Humans Language: En Journal: J Gastroenterol Hepatol Journal subject: GASTROENTEROLOGIA Year: 2024 Type: Article

Fulltext

XML

PubMed Links

Search on Google